Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2010, Article ID 867195, 9 pages
http://dx.doi.org/10.1155/2010/867195
Research Article

Diorganotin Complexes of a Thiosemicarbazone, Synthesis: Properties, X-Ray Crystal Structure, and Antiproliferative Activity of Diorganotin Complexes

1Sector of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece
2Faculty of Chemistry, University of Wrocław, 14 F. Joliot-Curie Street, 50-383 Wrocław, Poland
3Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, 11635 Athens, Greece

Received 8 February 2010; Accepted 31 March 2010

Academic Editor: Spyros Perlepes

Copyright © 2010 Joanna Wiecek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Blunden, P. A. Cusack, and R. Hill, Industrial Uses of Tin Chemicals, Royal Society of Chemistry, London, UK, 1985.
  2. V. Chandrasekhar, S. Nagendran, and V. Baskar, “Organotin assemblies containing Sn-O bonds,” Coordination Chemistry Reviews, vol. 235, no. 1-2, pp. 1–52, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Tabassum and C. Pettinari, “Chemical and biotechnological developments in organotin cancer chemotherapy,” Journal of Organometallic Chemistry, vol. 691, no. 8, pp. 1761–1766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Kovala-Demertzi, “Recent advances on non-steroidal anti-inflammatory drugs, NSAIDs: organotin complexes of NSAIDs,” Journal of Organometallic Chemistry, vol. 691, no. 8, pp. 1767–1774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Beraldo and D. Gambino, “The wide pharmacological versatility of semicarbazones, thiosemicarbozones and their metal complexes,” Mini-Reviews in Medicinal Chemistry, vol. 4, no. 1, pp. 31–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Gomez Quiroga and C. Navarro Ranninger, “Contribution to the SAR field of metallated and coordination complexes: studies of the palladium and platinum derivatives with selected thiosemicarbazones as antitumoral drugs,” Coordination Chemistry Reviews, vol. 248, no. 1-2, pp. 119–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Kovala-Demertzi, M. A. Demertzis, E. Filiou et al., “Platinum(II) and palladium(II) complexes with 2-acetyl pyridine 4N-ethyl thiosemicarbazone able to overcome the cis-platin resistance. Structure, antibacterial activity and DNA strand breakage,” BioMetals, vol. 16, no. 3, pp. 411–418, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Kovala-Demertzi, A. Boccarelli, M. A. Demertzis, and M. Coluccia, “In vitro antitumor activity of 2-acetyl pyridine 4N-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes,” Chemotherapy, vol. 53, no. 2, pp. 148–152, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. D. Kovala-Demertzi, P. Nath Yadav, J. Wiecek, S. Skoulika, T. Varadinova, and M. A. Demertzis, “Zinc(II) complexes derived from pyridine-2-carbaldehyde thiosemicarbazone and (1E)-1-pyridin-2-ylethan-1-one thiosemicarbazone. Synthesis, crystal structures and antiproliferative activity of zinc(II) complexes,” Journal of Inorganic Biochemistry, vol. 100, no. 9, pp. 1558–1567, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. R. A. Finch, M.-C. Liu, S. P. Grill et al., “Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone): a potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity,” Biochemical Pharmacology, vol. 59, no. 8, pp. 983–991, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Demertzis, P. Nath Yadav, and D. Kovala-Demertzi, “Palladium(II) complexes of the thiosemicarbazone and N- ethylthiosemicarbazone of 3-hydroxypyridine-2-carbaldehyde: synthesis, properties, and X-ray crystal structure,” Helvetica Chimica Acta, vol. 89, no. 9, pp. 1959–1970, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Kovala-Demertzi, A. Papageorgiou, L. Papathanasis et al., “In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents,” European Journal of Medicinal Chemistry, vol. 44, no. 3, pp. 1296–1302, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. D. Kovala-Demertzi, V. Dokorou, A. Primikiri et al., “Organotin meclofenamic complexes: synthesis, crystal structures and antiproliferative activity of the first complexes of meclofenamic acid—novel anti-tuberculosis agents,” Journal of Inorganic Biochemistry, vol. 103, no. 5, pp. 738–744, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. D. Kovala-Demertzi, A. Alexandratos, A. Papageorgiou, P. Nath Yadav, P. Dalezis, and M. A. Demertzis, “Synthesis, characterization, crystal structures, in vitro and in vivo antitumor activity of palladium(II) and zinc(II) complexes with 2-formyl and 2-acetyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone,” Polyhedron, vol. 27, no. 13, pp. 2731–2738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. M. Sheldrick, “Phase annealing in shelx-90- direct methods for larger structures,” Acta Crystallographica Section A, vol. 46, pp. 467–473, 1990. View at Google Scholar
  16. G. M. Sheldrick, “SHELXL-97,” Program for the Refinement of Crystal Structures, University of Goettingen, Goettingen, Germany, 1997. View at Google Scholar
  17. A. L. Spek, PLATON, A Multipurpose Crystallographic Tool, Utrecht University, Utrecht, The Netherlands, 2003.
  18. P. Skehan, R. Storeng, D. Scudiero et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990. View at Google Scholar · View at Scopus
  19. M. Ohno and T. Abe, “Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6),” Journal of Immunological Methods, vol. 145, no. 1-2, pp. 199–203, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, John Wiley & Sons, New York, NY, USA, 4th edition, 1986.
  21. J. Wiecek, V. Dokorou, Z. Ciunik, and D. Kovala-Demertzi, “Organotin complexes of pyruvic acid thiosemicarbazone: synthesis, crystal structures and antiproliferative activity of neutral and cationic diorganotin complexes,” Polyhedron, vol. 28, no. 15, pp. 3298–3304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Lycka, J. Jirman, and J. Holecek, “Magnitudes and relative signs of J(Sn-119, C-13) and J(Sn-119, H) coupling-constants in some organotin(IV) compounds using 2D Nmr methods,” Magnetic Resonance in Chemistry, vol. 29, no. 12, pp. 1212–1215, 1991. View at Google Scholar
  23. B. Wrackmeyer, “S119n-NMR parameters,” Annual Reports on NMR Spectroscopy, vol. 16, pp. 73–186, 1985. View at Publisher · View at Google Scholar
  24. M. C. Etter, “Encoding and decoding hydrogen-bond patterns of organic compounds,” Accounts of Chemical Research, vol. 23, no. 4, pp. 120–126, 1990. View at Google Scholar